Metraipolis › archive › dc_236258c13618
Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines — Europe PMC PMID:41828892
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41828892
- DOI
- 10.3390/molecules31050907
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T00:29:01.783Z
- SHA-256 of the archived text
3f7491f7db8b8cc5bc2b91826d33815961ff84f1c0451b1e509c5528969c84cf- Stable URL of this page
https://metraipolis.com/documento/dc_236258c13618
How to cite
Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines — Europe PMC PMID:41828892 — Europe PMC (en), https://europepmc.org/article/MED/41828892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_236258c13618 (Metraipolis archive dc_236258c13618, sha256 3f7491f7db8b8cc5bc2b91826d33815961ff84f1c0451b1e509c5528969c84cf)
BibTeX
@misc{dc236258c13618,
title = {Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines — Europe PMC PMID:41828892},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41828892},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_236258c13618; sha256 3f7491f7db8b8cc5bc2b91826d33815961ff84f1c0451b1e509c5528969c84cf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828892. Agents can read the archived copy with the MCP tool read_document.